Financials Scientific Industries, Inc.

Equities

SCND

US8087571084

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:51:19 2024-04-25 am EDT 5-day change 1st Jan Change
1.75 USD +2.34% Intraday chart for Scientific Industries, Inc. +34.62% -26.78%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5.498 11.42 22.89 38.75 38.52 24.25
Enterprise Value (EV) 1 4.136 9.628 16.47 26.82 33.75 19.85
P/E ratio -34.3 x 17.7 x -17.2 x -5.21 x -4.72 x -1.88 x
Yield - 0.66% - - - -
Capitalization / Revenue 0.65 x 1.12 x 2.67 x 3.96 x 3.68 x 2.18 x
EV / Revenue 0.49 x 0.94 x 1.92 x 2.74 x 3.22 x 1.79 x
EV / EBITDA 13.8 x 9.32 x -16.9 x -6.02 x -4.56 x -2.33 x
EV / FCF -54.4 x 80.5 x -42.4 x -23.7 x -9.51 x -6.45 x
FCF Yield -1.84% 1.24% -2.36% -4.22% -10.5% -15.5%
Price to Book 0.96 x 1.79 x 1.95 x 1.48 x 2.6 x 1.75 x
Nbr of stocks (in thousands) 1,494 1,503 2,861 6,458 7,004 10,145
Reference price 2 3.680 7.600 8.000 6.000 5.500 2.390
Announcement Date 9/28/18 10/4/19 10/9/20 10/14/21 7/7/23 3/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.481 10.2 8.57 9.775 10.48 11.11
EBITDA 1 0.2996 1.033 -0.9744 -4.457 -7.409 -8.506
EBIT 1 -0.0055 0.7761 -1.135 -4.709 -8.171 -9.26
Operating Margin -0.06% 7.61% -13.25% -48.17% -78% -83.34%
Earnings before Tax (EBT) 1 0.0014 0.7702 -1.14 -4.055 -8.146 -9.09
Net income 1 -0.1605 0.6456 -0.7033 -3.672 -8.159 -9.086
Net margin -1.89% 6.33% -8.21% -37.57% -77.88% -81.78%
EPS 2 -0.1074 0.4300 -0.4642 -1.151 -1.165 -1.270
Free Cash Flow 1 -0.076 0.1196 -0.3886 -1.132 -3.551 -3.081
FCF margin -0.9% 1.17% -4.53% -11.58% -33.9% -27.72%
FCF Conversion (EBITDA) - 11.58% - - - -
FCF Conversion (Net income) - 18.53% - - - -
Dividend per Share - 0.0500 - - - -
Announcement Date 9/28/18 10/4/19 10/9/20 10/14/21 7/7/23 3/29/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales 1 2.509 2.53 2.854 2.904 2.865
EBITDA 1 -1.815 -2.285 -1.359 -1.683 -1.488
EBIT 1 -1.859 -2.41 -1.524 -1.845 -1.742
Operating Margin -74.1% -95.25% -53.4% -63.52% -60.82%
Earnings before Tax (EBT) 1 -1.83 -1.85 -1.532 -1.321 -1.845
Net income 1 -1.436 -1.361 -1.209 -0.8965 -1.535
Net margin -57.23% -53.8% -42.35% -30.87% -53.58%
EPS 2 -0.5000 -0.3400 -0.1900 -0.1400 -0.2300
Dividend per Share - - - - -
Announcement Date 5/17/21 10/14/21 11/15/21 2/16/22 5/16/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.36 1.79 6.42 11.9 4.77 4.39
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.08 0.12 -0.39 -1.13 -3.55 -3.08
ROE (net income / shareholders' equity) -2.78% 10.7% -7.79% -16.4% -21.8% -63.4%
ROA (Net income/ Total Assets) -0.05% 6.22% -6.15% -13.4% -15.6% -33.3%
Assets 1 330.9 10.38 11.44 27.33 52.15 27.32
Book Value Per Share 2 3.820 4.240 4.100 4.060 2.110 1.370
Cash Flow per Share 2 0.7000 1.070 2.640 1.500 0.2800 0.0800
Capex 1 0.06 0.19 0.05 0.2 0.51 0.13
Capex / Sales 0.72% 1.84% 0.59% 2.03% 4.83% 1.19%
Announcement Date 9/28/18 10/4/19 10/9/20 10/14/21 7/7/23 3/29/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. SCND Stock
  4. Financials Scientific Industries, Inc.